Moderna, Inc. vs Sea Limited — how do they compare? Moderna, Inc. trades at $60.83 (market cap $24.18B), while Sea Limited trades at $129.95 (market cap $80.55B). The key difference: Sea Limited is far larger — about 3.3× Moderna, Inc.'s market cap, and Moderna, Inc. is trading nearer its 52-week high, Sea Limited nearer its low. Which is the better fit depends on your goals.
| MRNA | SE | |
|---|---|---|
Market Cap | $24.18B | $80.55B |
Sector | Health | Media |
52-Week High | $81.80 | $196.50 |
52-Week Low | $22.36 | $78.16 |
Enterprise Value | $20.33B | $75.58B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.
Read more on SE →